Low incidence of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study
Identifieur interne : 002363 ( Main/Exploration ); précédent : 002362; suivant : 002364Low incidence of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study
Auteurs : Joan Cid [Espagne, États-Unis] ; Miguel Lozano [Espagne] ; Alyssa Ziman [États-Unis] ; Kamille A. West [États-Unis] ; Kerry L. O'Brien [États-Unis] ; Michael F. Murphy [Royaume-Uni] ; Silvano Wendel [Brésil] ; Alejandro Vázquez [Espagne] ; Xavier Ortín [Espagne] ; Tor A. Hervig [Norvège] ; Meghan Delaney [États-Unis] ; Willy A. Flegel [États-Unis] ; Mark H. YazerSource :
- British journal of haematology [ 0007-1048 ] ; 2014.
Abstract
The reported frequency of D alloimmunization in D- recipients after transfusion of D+ platelets varies. This study was designed to determine the frequency of D alloimmunization, previously reported to be an average of 5%±2%. A primary anti-D immune response was defined as the detection of anti-D ≥28 days following the first D+ platelet transfusion. Data were collected on 485 D- recipients of D+ platelets in 11 centres between 2010-2012. Their median age was 60 (range 2-100) years. Diagnoses included: haematological (203/485, 42%), oncological (64/485, 13%) and other diseases (218/485, 45%). Only 7/485 (1.44%; 95%CI 0.58-2.97%) recipients had a primary anti-D response after a median serological follow-up of 77 days (range: 28-2111). There were no statistically significant differences between the primary anti-D formers and the other patients, in terms of gender, age, receipt of immunosuppressive therapy, proportion of patients with haematological/oncological diseases, transfusion of whole blood-derived or apheresis platelets or both, and total number of transfused platelet products. This is the largest study with the longest follow-up of D alloimmunization following D+ platelet transfusion. The low frequency of D alloimmunization should be considered when deciding whether to administer Rh Immune Globulin to D- males and D- females without childbearing potential after transfusion of D+ platelets.
Url:
DOI: 10.1111/bjh.13158
PubMed: 25283094
PubMed Central: 4314459
Affiliations:
- Brésil, Espagne, Norvège, Royaume-Uni, États-Unis
- Angleterre, Californie, Catalogne, Maryland, Massachusetts, Oxfordshire, Washington (État), État de São Paulo
- Barcelone, Oxford, São Paulo
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000E48
- to stream Pmc, to step Curation: 000E23
- to stream Pmc, to step Checkpoint: 000D97
- to stream Ncbi, to step Merge: 003877
- to stream Ncbi, to step Curation: 003877
- to stream Ncbi, to step Checkpoint: 003877
- to stream Main, to step Merge: 002461
- to stream Main, to step Curation: 002363
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Low incidence of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study</title><author><name sortKey="Cid, Joan" sort="Cid, Joan" uniqKey="Cid J" first="Joan" last="Cid">Joan Cid</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Lozano, Miguel" sort="Lozano, Miguel" uniqKey="Lozano M" first="Miguel" last="Lozano">Miguel Lozano</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ziman, Alyssa" sort="Ziman, Alyssa" uniqKey="Ziman A" first="Alyssa" last="Ziman">Alyssa Ziman</name><affiliation wicri:level="2"><nlm:aff id="A3">UCLA Division of Transfusion Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>UCLA Division of Transfusion Medicine, David Geffen School of Medicine at UCLA, Los Angeles</wicri:cityArea></affiliation></author><author><name sortKey="West, Kamille A" sort="West, Kamille A" uniqKey="West K" first="Kamille A." last="West">Kamille A. West</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="O Brien, Kerry L" sort="O Brien, Kerry L" uniqKey="O Brien K" first="Kerry L." last="O'Brien">Kerry L. O'Brien</name><affiliation wicri:level="2"><nlm:aff id="A4">Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, MA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Pathology, Beth Israel Deaconess Medical Centre, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Murphy, Michael F" sort="Murphy, Michael F" uniqKey="Murphy M" first="Michael F." last="Murphy">Michael F. Murphy</name><affiliation wicri:level="3"><nlm:aff id="A5">Oxford University Hospitals and NHS Blood & Transplant, Oxford, UK</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Oxford University Hospitals and NHS Blood & Transplant, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Wendel, Silvano" sort="Wendel, Silvano" uniqKey="Wendel S" first="Silvano" last="Wendel">Silvano Wendel</name><affiliation wicri:level="3"><nlm:aff id="A6">Hospital Sirio Libanes Blood Bank, São Paulo, BRAZIL</nlm:aff><country xml:lang="fr" wicri:curation="lc">Brésil</country><wicri:regionArea>Hospital Sirio Libanes Blood Bank, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region></placeName></affiliation></author><author><name sortKey="Vazquez, Alejandro" sort="Vazquez, Alejandro" uniqKey="Vazquez A" first="Alejandro" last="Vázquez">Alejandro Vázquez</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Blood Transfusion, Hospital Universitario Puerta de Hierro, Majadahonda, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Blood Transfusion, Hospital Universitario Puerta de Hierro, Majadahonda</wicri:regionArea><wicri:noRegion>Majadahonda</wicri:noRegion></affiliation></author><author><name sortKey="Ortin, Xavier" sort="Ortin, Xavier" uniqKey="Ortin X" first="Xavier" last="Ortín">Xavier Ortín</name><affiliation wicri:level="1"><nlm:aff id="A8">Department of Haematology, Hospital Verge de la Cinta, Tortosa, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haematology, Hospital Verge de la Cinta, Tortosa</wicri:regionArea><wicri:noRegion>Tortosa</wicri:noRegion></affiliation></author><author><name sortKey="Hervig, Tor A" sort="Hervig, Tor A" uniqKey="Hervig T" first="Tor A." last="Hervig">Tor A. Hervig</name><affiliation wicri:level="1"><nlm:aff id="A9">Haukeland University Hospital and Dept. of Clinical Science, University of Bergen, NORWAY</nlm:aff><country xml:lang="fr" wicri:curation="lc">Norvège</country><wicri:regionArea>Haukeland University Hospital and Dept. of Clinical Science, University of Bergen</wicri:regionArea><wicri:noRegion>University of Bergen</wicri:noRegion></affiliation></author><author><name sortKey="Delaney, Meghan" sort="Delaney, Meghan" uniqKey="Delaney M" first="Meghan" last="Delaney">Meghan Delaney</name><affiliation wicri:level="2"><nlm:aff id="A10">Puget Sound Blood Center and Department of Laboratory Medicine, University of Washington, Seattle, WA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Washington (État)</region></placeName><wicri:cityArea>Puget Sound Blood Center and Department of Laboratory Medicine, University of Washington, Seattle</wicri:cityArea></affiliation></author><author><name sortKey="Flegel, Willy A" sort="Flegel, Willy A" uniqKey="Flegel W" first="Willy A." last="Flegel">Willy A. Flegel</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Yazer, Mark H" sort="Yazer, Mark H" uniqKey="Yazer M" first="Mark H." last="Yazer">Mark H. Yazer</name><affiliation><nlm:aff id="A11">Department of Pathology, University of Pittsburgh and the Institute for Transfusion Medicine, Pittsburgh, PA.</nlm:aff><wicri:noCountry code="subfield">PA.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25283094</idno><idno type="pmc">4314459</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314459</idno><idno type="RBID">PMC:4314459</idno><idno type="doi">10.1111/bjh.13158</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000E48</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000E48</idno><idno type="wicri:Area/Pmc/Curation">000E23</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000E23</idno><idno type="wicri:Area/Pmc/Checkpoint">000D97</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000D97</idno><idno type="wicri:Area/Ncbi/Merge">003877</idno><idno type="wicri:Area/Ncbi/Curation">003877</idno><idno type="wicri:Area/Ncbi/Checkpoint">003877</idno><idno type="wicri:doubleKey">0007-1048:2014:Cid J:low:incidence:of</idno><idno type="wicri:Area/Main/Merge">002461</idno><idno type="wicri:Area/Main/Curation">002363</idno><idno type="wicri:Area/Main/Exploration">002363</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Low incidence of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study</title><author><name sortKey="Cid, Joan" sort="Cid, Joan" uniqKey="Cid J" first="Joan" last="Cid">Joan Cid</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Lozano, Miguel" sort="Lozano, Miguel" uniqKey="Lozano M" first="Miguel" last="Lozano">Miguel Lozano</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haemotherapy and Haemostasis, Hospital Clínic, IDIBAPS, UB, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ziman, Alyssa" sort="Ziman, Alyssa" uniqKey="Ziman A" first="Alyssa" last="Ziman">Alyssa Ziman</name><affiliation wicri:level="2"><nlm:aff id="A3">UCLA Division of Transfusion Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>UCLA Division of Transfusion Medicine, David Geffen School of Medicine at UCLA, Los Angeles</wicri:cityArea></affiliation></author><author><name sortKey="West, Kamille A" sort="West, Kamille A" uniqKey="West K" first="Kamille A." last="West">Kamille A. West</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="O Brien, Kerry L" sort="O Brien, Kerry L" uniqKey="O Brien K" first="Kerry L." last="O'Brien">Kerry L. O'Brien</name><affiliation wicri:level="2"><nlm:aff id="A4">Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, MA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Pathology, Beth Israel Deaconess Medical Centre, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Murphy, Michael F" sort="Murphy, Michael F" uniqKey="Murphy M" first="Michael F." last="Murphy">Michael F. Murphy</name><affiliation wicri:level="3"><nlm:aff id="A5">Oxford University Hospitals and NHS Blood & Transplant, Oxford, UK</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Oxford University Hospitals and NHS Blood & Transplant, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Wendel, Silvano" sort="Wendel, Silvano" uniqKey="Wendel S" first="Silvano" last="Wendel">Silvano Wendel</name><affiliation wicri:level="3"><nlm:aff id="A6">Hospital Sirio Libanes Blood Bank, São Paulo, BRAZIL</nlm:aff><country xml:lang="fr" wicri:curation="lc">Brésil</country><wicri:regionArea>Hospital Sirio Libanes Blood Bank, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region></placeName></affiliation></author><author><name sortKey="Vazquez, Alejandro" sort="Vazquez, Alejandro" uniqKey="Vazquez A" first="Alejandro" last="Vázquez">Alejandro Vázquez</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Blood Transfusion, Hospital Universitario Puerta de Hierro, Majadahonda, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Blood Transfusion, Hospital Universitario Puerta de Hierro, Majadahonda</wicri:regionArea><wicri:noRegion>Majadahonda</wicri:noRegion></affiliation></author><author><name sortKey="Ortin, Xavier" sort="Ortin, Xavier" uniqKey="Ortin X" first="Xavier" last="Ortín">Xavier Ortín</name><affiliation wicri:level="1"><nlm:aff id="A8">Department of Haematology, Hospital Verge de la Cinta, Tortosa, SPAIN</nlm:aff><country xml:lang="fr" wicri:curation="lc">Espagne</country><wicri:regionArea>Department of Haematology, Hospital Verge de la Cinta, Tortosa</wicri:regionArea><wicri:noRegion>Tortosa</wicri:noRegion></affiliation></author><author><name sortKey="Hervig, Tor A" sort="Hervig, Tor A" uniqKey="Hervig T" first="Tor A." last="Hervig">Tor A. Hervig</name><affiliation wicri:level="1"><nlm:aff id="A9">Haukeland University Hospital and Dept. of Clinical Science, University of Bergen, NORWAY</nlm:aff><country xml:lang="fr" wicri:curation="lc">Norvège</country><wicri:regionArea>Haukeland University Hospital and Dept. of Clinical Science, University of Bergen</wicri:regionArea><wicri:noRegion>University of Bergen</wicri:noRegion></affiliation></author><author><name sortKey="Delaney, Meghan" sort="Delaney, Meghan" uniqKey="Delaney M" first="Meghan" last="Delaney">Meghan Delaney</name><affiliation wicri:level="2"><nlm:aff id="A10">Puget Sound Blood Center and Department of Laboratory Medicine, University of Washington, Seattle, WA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Washington (État)</region></placeName><wicri:cityArea>Puget Sound Blood Center and Department of Laboratory Medicine, University of Washington, Seattle</wicri:cityArea></affiliation></author><author><name sortKey="Flegel, Willy A" sort="Flegel, Willy A" uniqKey="Flegel W" first="Willy A." last="Flegel">Willy A. Flegel</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea></affiliation></author><author><name sortKey="Yazer, Mark H" sort="Yazer, Mark H" uniqKey="Yazer M" first="Mark H." last="Yazer">Mark H. Yazer</name><affiliation><nlm:aff id="A11">Department of Pathology, University of Pittsburgh and the Institute for Transfusion Medicine, Pittsburgh, PA.</nlm:aff><wicri:noCountry code="subfield">PA.</wicri:noCountry></affiliation></author></analytic><series><title level="j">British journal of haematology</title><idno type="ISSN">0007-1048</idno><idno type="eISSN">1365-2141</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Summary</title><p id="P1">The reported frequency of D alloimmunization in D- recipients after transfusion of D+ platelets varies. This study was designed to determine the frequency of D alloimmunization, previously reported to be an average of 5%±2%. A primary anti-D immune response was defined as the detection of anti-D ≥28 days following the first D+ platelet transfusion. Data were collected on 485 D- recipients of D+ platelets in 11 centres between 2010-2012. Their median age was 60 (range 2-100) years. Diagnoses included: haematological (203/485, 42%), oncological (64/485, 13%) and other diseases (218/485, 45%). Only 7/485 (1.44%; 95%CI 0.58-2.97%) recipients had a primary anti-D response after a median serological follow-up of 77 days (range: 28-2111). There were no statistically significant differences between the primary anti-D formers and the other patients, in terms of gender, age, receipt of immunosuppressive therapy, proportion of patients with haematological/oncological diseases, transfusion of whole blood-derived or apheresis platelets or both, and total number of transfused platelet products. This is the largest study with the longest follow-up of D alloimmunization following D+ platelet transfusion. The low frequency of D alloimmunization should be considered when deciding whether to administer Rh Immune Globulin to D- males and D- females without childbearing potential after transfusion of D+ platelets.</p></div></front></TEI><affiliations><list><country><li>Brésil</li><li>Espagne</li><li>Norvège</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Californie</li><li>Catalogne</li><li>Maryland</li><li>Massachusetts</li><li>Oxfordshire</li><li>Washington (État)</li><li>État de São Paulo</li></region><settlement><li>Barcelone</li><li>Oxford</li><li>São Paulo</li></settlement></list><tree><noCountry><name sortKey="Yazer, Mark H" sort="Yazer, Mark H" uniqKey="Yazer M" first="Mark H." last="Yazer">Mark H. Yazer</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Cid, Joan" sort="Cid, Joan" uniqKey="Cid J" first="Joan" last="Cid">Joan Cid</name></region><name sortKey="Lozano, Miguel" sort="Lozano, Miguel" uniqKey="Lozano M" first="Miguel" last="Lozano">Miguel Lozano</name><name sortKey="Ortin, Xavier" sort="Ortin, Xavier" uniqKey="Ortin X" first="Xavier" last="Ortín">Xavier Ortín</name><name sortKey="Vazquez, Alejandro" sort="Vazquez, Alejandro" uniqKey="Vazquez A" first="Alejandro" last="Vázquez">Alejandro Vázquez</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Cid, Joan" sort="Cid, Joan" uniqKey="Cid J" first="Joan" last="Cid">Joan Cid</name></region><name sortKey="Delaney, Meghan" sort="Delaney, Meghan" uniqKey="Delaney M" first="Meghan" last="Delaney">Meghan Delaney</name><name sortKey="Flegel, Willy A" sort="Flegel, Willy A" uniqKey="Flegel W" first="Willy A." last="Flegel">Willy A. Flegel</name><name sortKey="O Brien, Kerry L" sort="O Brien, Kerry L" uniqKey="O Brien K" first="Kerry L." last="O'Brien">Kerry L. O'Brien</name><name sortKey="West, Kamille A" sort="West, Kamille A" uniqKey="West K" first="Kamille A." last="West">Kamille A. West</name><name sortKey="Ziman, Alyssa" sort="Ziman, Alyssa" uniqKey="Ziman A" first="Alyssa" last="Ziman">Alyssa Ziman</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Murphy, Michael F" sort="Murphy, Michael F" uniqKey="Murphy M" first="Michael F." last="Murphy">Michael F. Murphy</name></region></country><country name="Brésil"><region name="État de São Paulo"><name sortKey="Wendel, Silvano" sort="Wendel, Silvano" uniqKey="Wendel S" first="Silvano" last="Wendel">Silvano Wendel</name></region></country><country name="Norvège"><noRegion><name sortKey="Hervig, Tor A" sort="Hervig, Tor A" uniqKey="Hervig T" first="Tor A." last="Hervig">Tor A. Hervig</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002363 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002363 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4314459
|texte= Low incidence of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25283094" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |